Exhibit 10.5


          November 15, 1999


          American Electromedics Corp.
          13 Columbia Drive, Suite 5
          Amherst, NH  03031


          Gentleman:

          This letter sets forth the terms and conditions of the agreement
          relating to the purchase by Concord Effekten AG (the "purchaser")
          from American Electromedica Corp., a Delaware Corporation (the
          "Corporation"), of 1,333,333 shares (the "Shares") of common
          stock, par value $.10 per share of the Corporation.

          The Purchaser hereby purchases from the Corporation, and the
          Corporation hereby sells to the Purchaser, the Shares at a price
          of $.75 per Share, or an aggregate purchase price of $1,000,000
          (the "Purchase Price"), subject to the terms and conditions
          herein.  The Purchaser is hererby delivering a wire transfer to
          the Corporation for the Purchase Price, payment to be received by
          November 18, 1999, and upon receipt thereof the Corporation is
          delivering to the Purchaser a certificate representing the
          Shares.


          2.  The Purchaser represents and warrants to the Corporation
          that:
               2.1  The purchaser is aware that the Share have
                    not been registered under the Securities Act
                    of 1933, as amended (the "Securities Act"),
                    is aware of the restrictions on sale or
                    transfer thereunder, and acknowledges that an
                    appropriate restrictive legend will be set
                    forth on, and a stop transfer order will be
                    placed against, the certificate evidencing
                    the Shares to be issued to the Purchaser.
                    However, the Corporation agrees that it shall
                    include the Shares in a pre-effective
                    amendment to the registration statement filed
                    by the Corporation on Form SB-2 on March 31,
                    1999 (File No. 333-75399).

               2.2  The Purchaser has received and reviewed the
                    Corporation s Form 10-KSB for the fiscal year
                    ended July 31, 1999 and Preliminary Proxy
                    Statement for the 1999 Annual Meeting of
                    Stockholders, and has had the opportunity to
                    discuss the business, affairs and financial
                    prospects of the Corporation with management
                    of the Corporation and has made an informed
                    decision regarding the purchase of the
                    Shares.

               2.3  The Purchaser is an "accredited investor" as such term
                    is defined in Regulation D under the Securities Act.

               2.4  The Purchaser acknowledges that an investment in the
                    Corporation is highly speculative, that such investment
                    is consistent with his investment objectives and income
                    prospects, and that he has adequate means for providing
                    for his current financial needs, has no need for
                    liquidity in the investment herein, and is able to bear
                    the risk of loss of his entire investment in the
                    Shares.

          3.   The Corporation represents and warrants to the Purchaser
          that:

              3.1   The Corporation is a corporation duly
                    organized, validly existing and in good
                    standing under the laws of the State of
                    Delaware.  The authorized capital stock of
                    the Corporation is 20,000,000 shares of
                    Common Stock, of which 10,630,955 are issued
                    and outstanding, and 1,000,000 shares of
                    Preferred Stock, $.01 par value, of which
                    2,400 shares of Series A Preferred Stock and
                    1,170 shares of Series B Preferred Stock are
                    issued and outstanding.  Shares of Common
                    Stock are reserved for stock options and
                    warrants and conversion of the Series A and
                    Series B Preferred Stock.

               3.2  The Corporation has the full power and
                    authority to enter into this Agreement and to
                    sell the Shares, and that the Corporation s
                    execution, delivery and performance under
                    this Agreement has been duly authorized by
                    all necessary action.

               3.3  The Shares has been duly authorized, and upon
                    receipt of the Purchase Price will be fully
                    paid and nonassessable.

               3.4  The Corporation will be able to remove all
                    outstanding convertible preferred stock
                    within 3 business days of receipt of the
                    Purchase Price.

               3.5  The Corporation will send the Purchaser a
                    copy of the certificate representing the
                    Shares issued to the Purchaser by November
                    18, 1999.

               3.6  The Corporation is not aware of any reason
                    that would cause a significant delay in the
                    filing and acceptance by the SEC of the
                    pre-effective amendment to the registration
                    statement on Form SB-2, discussed in Section
                    2.1 of this agreement.

          4.   This letter sets forth the entire agreement between the
               parties hereto as to the subject matter herein, and
               cannot be amended, modified or terminated except by an
               agreement in writing executed by the parties hereto.
               In the event any provision of this letter is invalid or
               unenforceable, the remainder of this letter shall be
               construed without taking into effect such invalid or
               unenforceable provisions.  This letter shall be
               governed by the laws of the State of Delaware.

          Please signify your agreement to the foregoing by executing,
          faxing and returning the original of this letter.


                         Very truly yours,

                         CONCORD EFFEKTEN AG


                         By: /s/ Illegible
                            ----------------------

                         Name: Illegible
                              --------------------

                         Nibelungenplatz 3
                         60318 Frankfurt am Main
                         Germany

          Agreed to this 17th
          day of November, 1999

          AMERICAN ELECTROMEDICS CORP.


          By: /s/ Michael T. Pieniazek
             -----------------------------------
                Michael T. Pieniazek, President